|
1
|
Phillips RK, Hittinger R, Blesovsky L, et
al: Local recurrence following ‘curative’ surgery for large bowel
cancer: II. The rectum and rectosigmoid. Br J Surg. 71:17–20.
1984.
|
|
2
|
Faerden AE, Naimy N, Wiik P, et al: Total
mesorectal excision for rectal cancer: difference in outcome for
low and high rectal cancer. Dis Colon Rectum. 48:2224–2231. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enríquez-Navascués JM, Borda N, Lizerazu
A, et al: Patterns of local recurrence in rectal cancer after a
multidisciplinary approach. World J Gastroenterol. 17:1674–1684.
2011.PubMed/NCBI
|
|
4
|
Jatzko GR, Jagoditsch M, Lisborg PH, et
al: Long-term results of radical surgery for rectal cancer:
multivariate analysis of prognostic factors influencing survival
and local recurrence. Eur J Surg Oncol. 25:284–291. 1999.
View Article : Google Scholar
|
|
5
|
Yuan HY, Li Y, Yang GL, et al: Study on
the causes of local recurrence of rectal cancer after curative
resection: analysis of 213 cases. World J Gastroenterol. 4:527–529.
1998.PubMed/NCBI
|
|
6
|
Chen ZH, Song XM, Chen SC, et al: Risk
factors for adverse outcome in low rectal cancer. World J
Gastroenterol. 18:64–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mathis KL, Larson DW, Dozois EJ, et al:
Outcomes following surgery without radiotherapy for rectal cancer.
Br J Surg. 99:137–143. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Z, Xu H, Zhang W, et al: A
retrospective analysis of ultralow anterior resection vs.
abdomino-perineal resection for lower rectal cancer.
Hepatogastroenterology. 59:1780–1783. 2012.PubMed/NCBI
|
|
9
|
Martin ST, Heneghan HM and Winter DC:
Systematic review of outcomes after intersphincteric resection for
low rectal cancer. Br J Surg. 99:603–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boras Z, Kondza G, Sisljagić V, et al:
Prognostic factors of local recurrence and survival after curative
rectal cancer surgery: a single institution experience. Coll
Antropol. 36:1355–1361. 2012.
|
|
11
|
Bülow S, Christensen IJ, Iversen LH and
Harling H; Danish Colorectal Cancer Group. Intra-operative
perforation is an important predictor of local recurrence and
impaired survival after abdominoperineal resection for rectal
cancer. Colorectal Dis. 13:1256–1264. 2011.
|
|
12
|
Eriksen MT, Wibe A, Syse A, et al;
Norwegian Rectal Cancer Group; Norwegian Gastrointestinal Cancer
Group. Inadvertent perforation during rectal cancer resection in
Norway. Br J Surg. 91:210–216. 2004. View
Article : Google Scholar
|
|
13
|
Compton CC: Pathologic prognostic factors
in the recurrence of rectal cancer. Clin Colorectal Cancer.
2:149–160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koca D, Binicier C, Oztop I, et al:
Prognostic factors affecting recurrence and survival in patients
with locally advanced rectal cancer. J BUON. 17:291–298.
2012.PubMed/NCBI
|
|
15
|
Dresen RC, Peters EE, Rutten HJ, et al:
Local recurrence in rectal cancer can be predicted by
histopathological factors. Eur J Surg Oncol. 35:1071–1077. 2009.
View Article : Google Scholar
|
|
16
|
Parfitt JR and Driman DK: The total
mesorectal excision specimen for rectal cancer: a review of its
pathological assessment. J Clin Pathol. 60:849–855. 2007.
View Article : Google Scholar
|
|
17
|
Kuru B, Camlibel M, Dinç S, et al:
Prognostic factors affecting local recurrence and survival for
operable rectal cancers. J Exp Clin Cancer Res. 21:329–335.
2002.PubMed/NCBI
|
|
18
|
Yun HR, Lee LJ, Park JH, et al: Local
recurrence after curative resection in patients with colon and
rectal cancers. Int J Colorectal Dis. 23:1081–1087. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JH, Jang HS, Kim JG, et al:
Lymphovascular invasion is a significant prognosticator in rectal
cancer patients who receive preoperative chemoradiotherapy followed
by total mesorectal excision. Ann Surg Oncol. 19:1213–1221. 2012.
View Article : Google Scholar
|
|
20
|
Heald RJ and Ryall RD: Recurrence and
survival after total mesorectal excision for rectal cancer. Lancet.
1:1479–1482. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gosens MJ, Klaassen RA, Tan-Go I, et al:
Circumferential margin involvement is the crucial prognostic factor
after multimodality treatment in patients with locally advanced
rectal carcinoma. Clin Cancer Res. 13:6617–6623. 2007. View Article : Google Scholar
|
|
22
|
Wang C, Zhou ZG, Wang Z, Li L, Zheng YC,
Zhao GP, Chen DY and Liu WP: Mesorectal spread and micrometastasis
of rectal cancer studied with large slice technique and tissue
microarray. J Surg Oncol. 91:167–172. 2005. View Article : Google Scholar
|
|
23
|
Hansen MH, Balteskard L, Dørum LM, et al;
Norwegian Colorectal Cancer Group. Locally recurrent rectal cancer
in Norway. Br J Surg. 96:1176–1182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagtegaal ID and Quirke P: What is the
role for the circumferential margin in the modern treatment of
rectal cancer? J Clin Oncol. 26:303–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bernstein TE, Endreseth BH, Romundstad P
and Wibe A; Norwegian Colorectal Cancer Group. Circumferential
resection margin as a prognostic factor in rectal cancer. Br J
Surg. 96:1348–1357. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pacelli F, Sanchez AM, Covino M, et al:
Improved outcomes for rectal cancer in the era of preoperative
chemoradiation and tailored mesorectal excision: a series of 338
consecutive cases. Am Surg. 79:151–161. 2013.
|
|
27
|
Fitzgerald TL, Biswas T, O’Brien K, et al:
Neoadjuvant radiotherapy for rectal cancer: adherence to
evidence-based guidelines in clinical practice. World J Surg.
37:639–645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang J, Kim H, Hur H, et al:
Circumferential resection margin involvement in stage III rectal
cancer patients treated with curative resection followed by
chemoradiotherapy: A surrogate marker for local recurrence? Yonsei
Med J. 54:131–138. 2013. View Article : Google Scholar
|
|
29
|
Leite JS, Martins SC, Oliveira J, et al:
Clinical significance of macroscopic completeness of mesorectal
resection in rectal cancer. Colorectal Dis. 13:381–386. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rutkowski A, Nowacki MP, Chwalinski M, et
al: Acceptance of a 5-mm distal bowel resection margin for rectal
cancer: is it safe? Colorectal Dis. 14:71–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park JH, Kim HC, Cho YK, et al: Narrow
distal resection margin may be sufficient for rectal cancer after
chemoradiation. Hepatogastroenterology. 58:769–774. 2011.
|
|
32
|
Kwak JY, Kim CW, Lim SB, et al:
Oncologically safe distal resection margins in rectal cancer
patients treated with chemoradiotherapy. J Gastrointest Surg.
16:1947–1954. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bujko K, Rutkowski A, Chang GJ, et al: Is
the 1-cm rule of distal bowel resection margin in rectal cancer
based on clinical evidence? A systematic review. Ann Surg Oncol.
19:801–808. 2012. View Article : Google Scholar
|
|
34
|
Young JR, Chang HK, Hun JK, et al:
Clinical significance of serial serum carcinoembryonic antigen
values for treating rectal cancer with preoperative
chemoradiotherapy. J Korean Soc Coloproctol. 28:205–212. 2012.
View Article : Google Scholar
|
|
35
|
Lin JK, Lin CC, Yang SH, et al: Early
postoperative CEA level is a better prognostic indicator than is
preoperative CEA level in predicting prognosis of patients with
curable colorectal cancer. Int J Colorectal Dis. 26:1135–1141.
2011. View Article : Google Scholar
|
|
36
|
Glimelius B, Grönberg H, Järhult J, et al:
A systematic overview of radiation therapy effects in rectal
cancer. Acta Oncol. 42:476–492. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fleming FJ, Påhlman L and Monson JR:
Neoadjuvant therapy in rectal cancer. Dis Colon Rectum. 54:901–912.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Braendengen M, Tveit KM, Berglund A, et
al: Randomized phase III study comparing preoperative radiotherapy
with chemoradiotherapy in nonresectable rectal cancer. J Clin
Oncol. 26:3687–3694. 2008. View Article : Google Scholar
|
|
39
|
Kusters M, Valentini V, Calvo A, et al:
Results of European pooled analysis of IORT-containing
multimodality treatment for locally advanced rectal cancer:
adjuvant chemotherapy prevents local recurrence rather than distant
metastases. Ann Oncol. 21:1279–1284. 2010. View Article : Google Scholar
|
|
40
|
Wanebo HJ, Koness RJ, Vezeridis MP, et al:
Pelvic resection of recurrent rectal cancer. Ann Surg. 220:586–597.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reerink O, Mulder NH, Botke G, et al:
Treatment of locally recurrent rectal cancer, results and
prognostic factors. Eur J Surg Oncol. 30:954–958. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wanebo HJ, Antoniuk P, Koness RJ, et al:
Pelvic resection of recurrent rectal cancer: technical
considerations and outcomes. Dis Colon Rectum. 42:1438–1448. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Suzuki K, Dozois RR, Devine RM, et al:
Curative reoperations for locally recurrent rectal cancer. Dis
Colon Rectum. 39:730–736. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hahnloser D, Nelson H, Gunderson LL, et
al: Curative potential of multimodality therapy for locally
recurrent rectal cancer. Ann Surg. 237:502–508. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pergolizzi S, Settineri N, Santacaterina
A, et al: Prognostic factors in ambulatory patients with inoperable
locoregionally recurrent rectal cancer following curative surgery.
Anticancer Res. 19:1383–1390. 1999.
|
|
46
|
Uemura M, Ikeda M, Noura S, et al: The
features of late local recurrences following curative surgery for
rectal cancer. Hepatogastroenterology. 59:1800–1803.
2012.PubMed/NCBI
|
|
47
|
Caricato M, Borzomati D, Ausania F, et al:
Prognostic factors after surgery for locally recurrent rectal
cancer: an overview. Eur J Surg Oncol. 32:126–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Asoglu O, Karanlik H, Muslumanoglu M, et
al: Prognostic and predictive factors after surgical treatment for
locally recurrent rectal cancer: a single institute experience. Eur
J Surg Oncol. 33:1199–1206. 2007. View Article : Google Scholar
|
|
49
|
Pacelli F, Tortorelli AP, Rosa F, et al:
Locally recurrent rectal cancer: prognostic factors and long-term
outcomes of multimodal therapy. Ann Surg Oncol. 17:152–162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang Y, Wan YL, Liu YC, et al: Surgical
outcomes for 187 patients with locally recurrent rectal cancer and
analysis of prognostic factors. Zhonghua Wei Chang Wai Ke Za Zhi.
14:582–585. 2011.(In Chinese).
|
|
51
|
Rahbari NN, Ulrich AB, Bruckner T, et al:
Surgery for locally recurrent rectal cancer in the era of total
mesorectal excision: is there still a chance for cure? Ann Surg.
253:522–533. 2011. View Article : Google Scholar
|
|
52
|
Heriot AG, Byrne CM, Lee P, et al:
Extended radical resection: the choice for locally recurrent rectal
cancer. Dis Colon Rectum. 51:284–291. 2008. View Article : Google Scholar
|
|
53
|
Harji DP, Sagar PM, Boyle K, et al:
Outcome of surgical resection of second-time locally recurrent
rectal cancer. Br J Surg. 100:403–409. 2013. View Article : Google Scholar
|
|
54
|
Wiig JN, Larsen SG, Dueland S, et al:
Salvage surgery for locally recurrent rectal cancer: total
mesorectal excision during the primary operation does not influence
the outcome. Colorectal Dis. 13:506–511. 2011. View Article : Google Scholar
|
|
55
|
Wiig JN, Wolff PA, Tveit KM and Giercksky
KE: Location of pelvic recurrence after ‘curative’ low anterior
resection for rectal cancer. Eur J Surg Oncol. 25:590–594.
1999.
|
|
56
|
Moore HG, Shoup M, Riedel E, et al:
Colorectal cancer pelvic recurrences: determinants of
resectability. Dis Colon Rectum. 47:1599–1606. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kusters M, Dresen RC, Martijin H, et al:
Radicality of resection and survival after multimodality treatment
is influenced by subsite of locally recurrent rectal cancer. Int J
Radiat Oncol Biol Phys. 75:1444–1449. 2009. View Article : Google Scholar
|
|
58
|
Yamada K, Ishizawa T, Niwa K, et al:
Patterns of pelvic invasion are prognostic in the treatment of
locally recurrent rectal cancer. Br J Surg. 88:988–993. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dozois EJ, Privitera A, Holubar SD, et al:
High sacrectomy for locally recurrent rectal cancer: Can long-term
survival be achieved? J Surg Oncol. 103:105–109. 2011. View Article : Google Scholar
|
|
60
|
Kido A, Koyama F, Akahane M, et al: Extent
and contraindications for sacral amputation in patients with
recurrent rectal cancer: a systematic literature review. J Orthop
Sci. 16:286–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hugate RR Jr, Dickey ID, Phimolsarnti R,
et al: Mechanical effects of partial sacrectomy: when is
reconstruction necessary? Clin Orthop Relat Res. 450:82–88. 2006.
View Article : Google Scholar
|
|
62
|
Davidge KM, Eskicioglu C, Lipa J, et al:
Qualitative assessment of patient experiences following sacrectomy.
J Surg Oncol. 101:447–450. 2010.PubMed/NCBI
|
|
63
|
Cheng L, Yu Y, Zhu R, et al: Structural
stability of different reconstruction techniques following total
sacrectomy: a biomechanical study. Clin Biomech (Bristol, Avon).
26:977–981. 2011. View Article : Google Scholar
|
|
64
|
Dassanayake BK, Samita S, Deen RY, et al:
Local recurrence of rectal cancer in patients not receiving
neoadjuvant therapy - the importance of resection margins. Ceylon
Med J. 56:159–161. 2011. View Article : Google Scholar
|
|
65
|
Ceyhan GO, Liebl F, Maak M, et al: The
severity of neural invasion is a crucial prognostic factor in
rectal cancer independent of neoadjuvant radiochemotherapy. Ann
Surg. 252:797–804. 2010. View Article : Google Scholar
|
|
66
|
Bae SH, Park W, Choi DH, et al: Palliative
radiotherapy in patients with a symptomatic pelvic mass of
metastatic colorectal cancer. Radiat Oncol. 6:522011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Mannaerts GH, Martijin H, Crommelin MA, et
al: Feasibility and first results of multimodality treatment,
combining EBRT, extensive surgery, and IOERT in locally advanced
primary rectal cancer. Int J Radiat Oncol Biol Phys. 47:425–433.
2000. View Article : Google Scholar
|
|
68
|
Hashiguchi Y, Sekine T, Sakamoto H, et al:
Intraoperative irradiation after surgery for locally recurrent
rectal cancer. Dis Colon Rectum. 42:886–893. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Guo S, Reddy CA, Kolar M, et al:
Intraoperative radiation therapy with the photon radiosurgery
system in locally advanced and recurrent rectal cancer:
retrospective review of the Cleveland clinic experience. Radiat
Oncol. 7:1102012. View Article : Google Scholar
|
|
70
|
Gunderson LL, Nelson H, Martenson JA, et
al: Intraoperative electron and external beam irradiation with or
without 5-fluorouracil and maximum surgical resection for
previously unirradiated, locally recurrent colorectal cancer. Dis
Colon Rectum. 39:1379–1395. 1996. View Article : Google Scholar
|
|
71
|
Dresen RC, Gosens MJ, Martijn H, et al:
Radical resection after IORT-containing multimodality treatment is
the most important determinant for outcome in patients treated for
locally recurrent rectal cancer. Ann Surg Oncol. 15:1937–1947.
2008. View Article : Google Scholar
|
